Rhythm Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RYTM Nasdaq 2836 rhythmtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones - Jan 9th, 2026 6:00 am
Rhythm Pharmaceuticals Phase 2 Setmelanotide Data Show 'Encouraging' Early Activity, Morgan Stanley Says - Dec 12th, 2025 9:08 am
Praxis tees up another approval filing; Geron turns to layoffs - Dec 12th, 2025 3:18 am
Rhythm Pharmaceuticals (RYTM): Reassessing Valuation After Positive Prader-Willi Data and Phase 3 Trial Plans - Dec 12th, 2025 2:11 am
Is It Too Late to Invest in Rhythm Pharmaceuticals After Its 2025 Rally? - Dec 12th, 2025 12:08 am
Rhythm Pharma Hits Record High On Unexpected Obesity-Tied Win - Dec 11th, 2025 2:27 pm
Sector Update: Health Care Stocks Advance Late Afternoon - Dec 11th, 2025 1:58 pm
Sector Update: Health Care Stocks Rise Thursday Afternoon - Dec 11th, 2025 11:45 am
Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome - Dec 11th, 2025 5:30 am
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome - Dec 10th, 2025 2:01 pm
The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch. - Dec 4th, 2025 9:10 am
Brinker upgraded, Coinbase downgraded: Wall Street's top analyst calls - Nov 25th, 2025 7:36 am
3 Prominent Stocks Estimated To Be Up To 35.1% Below Intrinsic Value - Nov 20th, 2025 4:38 am
Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025 - Nov 10th, 2025 5:00 am
Sector Update: Health Care Stocks Retreat Friday Afternoon - Nov 7th, 2025 12:01 pm
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates - Nov 7th, 2025 11:44 am
Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity - Nov 7th, 2025 5:30 am
Rhythm Pharmaceuticals (RYTM): Losses Have Averaged 18.8% Growth Annually; Revenue Forecast +45.8% Heading Into Earnings - Nov 5th, 2025 7:19 pm
Rhythm Pharmaceuticals Announces Public Reimbursement for IMCIVREE® (setmelanotide) in Canada in Five Provinces and Under the Federal Non-Insured Health Benefits Program - Nov 5th, 2025 2:01 pm
Rhythm Pharmaceuticals Inc (RYTM) Q3 2025 Earnings Call Highlights: Revenue Growth and ... - Nov 4th, 2025 2:03 pm